Federal Circuit Revives University of Pennsylvania Gene Therapy Patent, Clarifies Biotech Patent Eligibility Rules
The Federal Circuit’s recent decision to revive the University of Pennsylvania’s gene therapy patent has introduced much-needed clarity in the realm of patent eligibility for biotechnology innovations. The ruling establishes a clear, bright-line rule that many in the legal community believe has been absent in patent law debates. The court’s decision underscores the distinctiveness of…